Nuclear hormone receptors are transcription factors that require multiple protein-protein interactions to regulate the expression of their target genes. Using the yeast two-hybrid system, we identified a protein, thyroid hormone receptor uncoupling protein (TRUP), that specifically interacts with a region of the human thyroid hormone receptor (TR) consisting of the hinge region and the N-terminal portion of the ligand binding domain in a hormone-independent manner. Interestingly, TRUP inhibits transactivation by TR and the retinoic acid receptor but has no effect on the estrogen receptor or the retinoid X receptor in mammalian cells (18) . pCMV4-TRUP (where TRUP is TR incoupling protein) was constructed from pBK-CMV-TRUP. pBK-CMV-TRUP was created by first inserting the Xho I fragment of pACT-TRUP (cor 1.3) into the Xho I site of pBK-CMV (Stratagene) followed by sequencing to determine the correct orientation. The HindIII-Xba I fragment of pBK-CMV-TRUP was then inserted into the HindIII-Xba I sites of pCMV4 (19) to create pCMV4-TRUP. Two-Hybrid System. The yeast strain y190 (MATa, 112, gal4Agall8OA URA3 GAL-lacZ, LYS GAL-HIS3, cyhr) containing pASlcyh TR168-259 was transformed with a human B-lymphocyte cDNA library in pACT (14) and plated on SC medium lacking tryptophan, leucine, and histidine (containing 25 mM 3-aminotriazole) as described by Durfee et al. (14) . His' colonies exhibiting ,B-galactosidase activity using the filter lift assay were further characterized. 3-Galactosidase activity was determined using chlorophenyl red f3-D-galactopyranoside (CPRG) as described (14) . To recover the library plasmids, total DNA from yeast was isolated and used to transform Escherichia coli
tion of the ligand binding domain in a hormone-independent manner. Interestingly, TRUP inhibits transactivation by TR and the retinoic acid receptor but has no effect on the estrogen receptor or the retinoid X receptor in mammalian cells. We also demonstrate that TRUP exerts its action on TR and retinoic acid receptor by interfering with their abilities to interact with their DNA. TRUP represents a type of regulatory protein that modulates the transcriptional activity of a subclass of the nuclear hormone receptor superfamily by pre- venting interaction with their genomic response elements.
Members of the nuclear hormone receptor superfamily are ligand-activated transcription factors (1) (2) (3) (4) . This superfamily includes the receptors for steroid hormones, thyroid hormones, lipophilic vitamins such as vitamins A and D, and the orphan receptors, which have structure consistent with other superfamily members but have no identified ligands. Nuclear receptors regulate gene expression by interacting with specific DNA sequences (response elements) in the promoters of target genes (5, 6) . Receptors for the classical steroid hormones bind to their respective response elements in a liganddependent manner; however, some receptors such as the thyroid hormone receptor (TR) and retinoic acid receptor (RAR) bind to their response elements in a ligand-independent manner. The receptors modulate the rate of transcription of target genes by interacting with basal transcription machinery either directly (7) (8) (9) (10) or indirectly via TATA binding protein-associated factors (11) . The interaction of nuclear receptors with the basal transcriptional machinery may also be regulated by ligand binding. TR is an example of this level of regulation by ligand binding. In the absence of ligand, the ligand binding domain (LBD) of TR interacts with the basal transcription factor, TFIIB. In the presence of ligand this region of TR fails to interact with TFIIB (8) . This complex ligand-dependent interaction of TR with TFIIB may play a role in the mechanism by which TR silences target gene transcription in the absence of ligand and activates target gene transcription in the presence of ligand (8, 12) .
Recently, we demonstrated that TR must interact with a protein(s), termed a corepressor, to silence gene transcription (13) . The corepressor interacts with a small region of TR consisting of the hinge region and the N-terminal portion of the LBD (amino acids 168-259). Using the yeast two-hybrid system, we attempted to identify the corepressor that interacts with this region of TR. In the course of these experiments, we serendipitously identified a protein that inhibits the ability of TR and the RAR to transactivate target genes.
MATERIALS AND METHODS
Plasmid Construction. The GAL4 DBD-TR168-259 yeast expression plasmid (pASlcyh-TR168-259) (where DBD is DNA binding domain) was constructed by inserting the BamHI/HindIII (filled) fragment of pAI3Agal TR168-259 (13) into the BamHI/Sal I (filled) sites of pAS1-cyh (14) . pTRE2LacZ was constructed by inserting two copies of a DR4 oligonucleotide (15) into the Bgl II site of PC3 (16). pl7merLacZ has been described previously (17) . To construct pCBUB GAL TR168-456, HindlIl-digested (and filled) pAB Gal TR168-456 was partially digested with Bgl II. The resulting Bgl II-HindIll (filled) fragment was inserted into the Nco I-Pvu II sites of pCBUB linker (17) . YepTR(3 was constructed by first inserting an EcoRI fragment containing the entire coding sequence of human TR f3 (hTR,B) into BCpV2 (18) .
The Afl II/Kpn I fragment of this vector was then subcloned into the corresponding sites of the yeast expression vector YepVl (18) . pCMV4-TRUP (where TRUP is TR incoupling protein) was constructed from pBK-CMV-TRUP. pBK-CMV-TRUP was created by first inserting the Xho I fragment of pACT-TRUP (cor 1.3) into the Xho I site of pBK-CMV (Stratagene) followed by sequencing to determine the correct orientation. The HindIII-Xba I fragment of pBK-CMV-TRUP was then inserted into the HindIII-Xba I sites of pCMV4 (19) to create pCMV4-TRUP. Two-Hybrid System. The yeast strain y190 (MATa, leu2-3, 112, ura3-52, trpl-901, his2-D200, ade2-101, gal4Agall8OA URA3 GAL-lacZ, LYS GAL-HIS3, cyhr) containing pASlcyh TR168-259 was transformed with a human B-lymphocyte cDNA library in pACT (14) and plated on SC medium lacking tryptophan, leucine, and histidine (containing 25 mM 3-aminotriazole) as described by Durfee et al. (14) . His' colonies exhibiting ,B-galactosidase activity using the filter lift assay were further characterized. 3-Galactosidase activity was determined using chlorophenyl red f3-D-galactopyranoside (CPRG) as described (14) . 
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(HB101). Transformants were identified on minimal medium lacking leucine and containing ampicillin. To ensure that the correct cDNAs were identified, library plasmids isolated were retransformed into y190 containing pASlcyhTR168-259 and 3-galactosidase activity was determined. The specificity of the interaction of TRUP with TR was determined by mating y190 containing pACT-TRUP with the strain y187 (MATa, gal4, gal80, his3, trpl-901, ade2-101, ura3-52, leu2-3,-112, URA3 GAL-lacZ met-) containing either pAS1-SNF, pAS1-CDK2, pAS1-p53, or pAS1-lamin. The /3-galactosidase activity of these diploids was examined using the filter lift and CPRG methods. The interaction of TRUP with GAL TR 168-456 and full-length TR was examined using a modified two-hybrid system. The yeast strain BJ2168 (genotype MATa, prcl-407, Prbl-1122, pep4-3, leuZ trpl, ura 3-52) was transformed with either pCBUB GAL TR 168-456 or YepTR and their corresponding reporters (pl7mer LacZ and pTRE2 LacZ, respectively). Also included was empty pACT for controls or pACT-TRUP. ,B-Galactosidase activity was quantitated as described (17) .
Transfections. Transfections of the Lmtk-cells and chloramphenicol acetyltransferase (CAT) assays were performed as described (20) . Equivalent amounts of empty expression vector (pCMV4) were included in cells cotransfected with only a receptor and reporter and not pCMV4-TRUP. The expression a B C D and reporter plasmids pRSV-TR, pRSV-RAR, pRSV-RXR, pRSV-ER, DR4-tkCAT, DR5-tkCAT, DR1-tkCAT, and ERE2-tkCAT have been described (15, (21) (22) (23) . Electrophoretic Mobility Shift Assay (EMSA). All proteins used in the EMSA were in vitro translated using the TNT system (Promega) according to the manufacturer's protocol. The plasmids used for in vitro translation of the receptors, pT7-TR, pT7-RAR, pT7-RXR, and pT7-ER, have been described (15, (21) (22) (23) . pBK-CMV-TRUP was used to in vitro translate TRUP. The EMSA was performed using unlabeled translated receptors that were preincubated for 15 min at room temperature with unlabeled in vitro translated TRUP in a total volume of 8 ,ul [containing 2 ,ul of 5x bandshift buffer (1x bandshift buffer = 60 mM KCl/5 mM MgCl2/20 mM Hepes, pH 7.5/2 mM dithiothreitol/10% glycerol)]. Approximately equal amounts of receptor and TRUP were incubated, as determined by SDS/PAGE analysis of 35S-labeled protein made in parallel with the unlabeled protein used in the EMSA. Two microliters of a solution containing 0.1 ng of 32P-labeled DNA response element and 300 ng of pGEM (digested with Hpa II) was added to the reaction mixture and incubated an additional 15 min at room temperature. The response elements (DR1, DR4, DR5, and estrogen receptor response element) and the methods for their labeling have been described (15, 23) . Protein-DNA complexes were resolved on a 5% polyacrylamide gel (15 
interacts with the hTR,3 using the yeast (Fig. 2a,  lanes 3 and 4) . However, in cells cotransfected with TRUP, TR was no longer able to activate reporter gene transcription (Fig.  2a, lane 6) . The inhibitory effect of TRUP on TR transactivation was dose dependent (data not shown). Furthermore, in the presence of TRUP, TR was less effective in silencing the basal transcription of a reporter gene in the absence of ligand (data not shown).
To examine whether the inhibitory effect of TRUP is specific for TR, we also examined the effects of TRUP on RAR, a nuclear hormone receptor closely related to TR. full-length RAR and a reporter containing a RAR response element (DR5) upstream of tkCAT (15) in the presence or absence of an expression vector for TRUP. In cells transfected with RAR and the reporter, normal hormone-dependent activation of the reporter was observed (Fig. 2b, lanes 3 and 4) and, in a manner similar to TR, overexpression of TRUP antagonized the ability of RAR to transactivate (Fig. 2b, lane  6) . To examine the specificity of the inhibitory effects of TRUP, we overexpressed TRUP along with ER and RXR and their respective reporters. TRUP had no effect on the abilities of these nuclear receptors to transactivate their target genes (Fig. 2 c and d) . Overexpression of TRUP alone did not affect any of the reporters examined.
We were able to demonstrate in the two-hybrid system that TRUP interacts with and increases the transcriptional activity of GAL4 DBD-TR 168-456; however, TRUP decreases the transcriptional activity of full-length TR. The major difference between these two TR constructs is that the GAL4 DBD-TR 168-456 utilizes the GAL4 DBD and the full-length TR construct uses its natural DBD. Therefore, we hypothesized that TRUP may inhibit full-length TR function by interfering with the natural DNA 2) . However, if the heterodimer is preincubated with an equal amount of TRUP (as determined by SDS/PAGE analysis) the ability of TR-RXR to bind the element is significantly decreased (Fig. 3a, lanes 3 and 4) . Similar results were noted with the RARRXR heterodimer (Fig. 3b) . A stoichiometric amount of TRUP is able to inhibit the ability of RAR-RXR heterodimers to bind to a DR5 element (Fig. 3b) . 
